Population
Patients with specific pathophysiologic states of cardiac etiology, including atrioventricular block…
Design
Review
Authors
Loading...
May support adjunctive aminophylline in refractory bradyarrhythmias or HF; leaves open need for randomized confirmation before practice change.
Aminophylline should not be considered an archaic agent, as it retains potential benefit as adjunctive therapy in specific cardiac conditions such as AV block, cardiac arrest, heart failure, and bradyarrhythmias.
Basil M. RuDusky (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: